Sutro Biopharma STRO Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Sutro Biopharma in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sutro Biopharma's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sutro Biopharma's accounts payable?
- Sutro Biopharma (STRO) reported accounts payable of $5.49M in Q1 2026.
- How has Sutro Biopharma's accounts payable changed year-over-year?
- Sutro Biopharma's accounts payable decreased by 32.9% year-over-year, from $8.18M to $5.49M.
- What is the long-term trend for Sutro Biopharma's accounts payable?
- Over 5 years (2020 to 2025), Sutro Biopharma's accounts payable has grown at a 6.4% compound annual growth rate (CAGR), from $5.54M to $7.57M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.